# Autologous Endothelial Progenitor Cells Treatment of Diabetic Foot

> **NCT02474381** · NA · UNKNOWN · sponsor: **Shanghai 10th People's Hospital** · enrollment: 60 (estimated)

## Conditions studied

- Diabetic Foot

## Interventions

- **BIOLOGICAL:** EPCs plus PTA
- **DEVICE:** Single PTA

## Key facts

- **NCT ID:** NCT02474381
- **Lead sponsor:** Shanghai 10th People's Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-12
- **Primary completion:** 2016-11
- **Final completion:** 2016-11
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2015-06-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02474381

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02474381, "Autologous Endothelial Progenitor Cells Treatment of Diabetic Foot". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT02474381. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*